Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy

BACKGROUND: The efficacy of dendritic cell (DC) immunotherapy as a single therapeutic modality for the treatment of glioblastoma (GBM) patients remains limited. In this study, we evaluated in patients with GBM recurrence the immune-mediated effects of DC loaded with autologous tumor lysate combined...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurooncol Adv
Auteurs principaux: Eoli, Marica, Corbetta, Cristina, Anghileri, Elena, Di Ianni, Natalia, Milani, Micaela, Cuccarini, Valeria, Musio, Silvia, Paterra, Rosina, Frigerio, Simona, Nava, Sara, Lisini, Daniela, Pessina, Sara, Maddaloni, Luisa, Lombardi, Raffaella, Tardini, Maria, Ferroli, Paolo, DiMeco, Francesco, Bruzzone, Maria Grazia, Antozzi, Carlo, Pollo, Bianca, Finocchiaro, Gaetano, Pellegatta, Serena
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7212883/
https://ncbi.nlm.nih.gov/pubmed/32642658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz022
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires